bemethyl has been researched along with Chronic-Disease* in 3 studies
1 trial(s) available for bemethyl and Chronic-Disease
| Article | Year |
|---|---|
[Effect of bemithyl (bemactor) on the bronchial epithelium regeneration and the main protector mechanisms of the respiratory system in chronic inflammation].
To improve the efficiency of the therapy of respiratory diseases, the influence of a drug belonging to the group of actoprotectors--bemithyl (bemactor) on the main protector mechanisms of respiratory organs was evaluated, using functional-morphological studies of mucocilliary apparatus and local bronchial immunity. Bemithyl was found to produce no direct influence on these mechanisms, but the use of bemithyl by special technology is perspective for these purposes. Topics: Adjuvants, Immunologic; Benzimidazoles; Bronchi; Bronchitis; Chronic Disease; Epithelium; Humans; Regeneration | 1999 |
2 other study(ies) available for bemethyl and Chronic-Disease
| Article | Year |
|---|---|
[A new approach to the therapy of pyoderma in servicemen: the use of the actoprotector bemitil].
At 51 men at the age from 20 till 30, sick with pyodermatitis, the clinical-immunological aspects and efficiency of-actoprotector, capable to support motor activity and human performance in the extreme environments. Bemitil has appeared more effective in comparison with conventional therapy: by general and combined application the parameters of immunity have been normalized statistically authentically, and at outside application-the places of damage were cleared faster, disappeared painfulness, hyperemia, edema, terms of staying in the hospital were reduced. The clinical recovery was in 86.3 +/- 4.8% of the patients, while effectiveness from conventional means was 62.1 +/- 6.8%. Topics: Adjuvants, Immunologic; Adult; Antibody Formation; Benzimidazoles; Chronic Disease; Drug Evaluation; Humans; Immunity, Cellular; Military Personnel; Ointments; Pyoderma; Recurrence; Russia; Tablets | 1998 |
[The stimulation of pulmonary epithelial regeneration and of the clearance function of the mucociliary apparatus by using bemetil].
A method of stimulation of the bronchial epithelium regeneration and mucociliary apparatus function is described. The effect is achieved with the help of bemithyl, an agent of the actoprotector group. In combination with immunocorrection, this effect is potentiated. The method is quite simple and may be extensively used in experimental investigations and clinical practice. Topics: Benzimidazoles; Bronchiectasis; Bronchitis; Chronic Disease; Drug Evaluation; Epithelium; Humans; Lung; Mucociliary Clearance; Regeneration; Stimulation, Chemical | 1995 |